Bladder cancer: better clinical outcomes with BCG Connaught than Tice.
Sarah
S
Payton
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality*
D001500:BCG Vaccine